Perdagangan Novavax NVAX

Novavax diagram langsung

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

Novavax news

2021 Mei 11, 13:20

US pre-market: selling unabated

2021 Mei 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 Mei 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Berita Terkini

Tampilkan lebih banyak
Ava Grace 2025 Jul 17, 13:20

US Consumer Spending Defies Tariff Impact: Resilience or Price Inflation?

Ava Grace 2025 Jul 17, 10:21

Gold Price Forecast 2025-2026: A Comprehensive Analysis by the World Gold Council

Sophia Claire 2025 Jul 17, 10:20

EU Prepares Retaliatory Measures Against US Amid Trade Dispute

Sophia Claire 2025 Jul 17, 07:20

Analyzing Trump's Tariff Threats: Are European Markets Underestimating the Risk?

Liam James 2025 Jul 17, 06:20

Iran's Khamenei: Ready for Stronger Response to Potential Attacks

Noah Lee 2025 Jul 17, 05:20

US House Advances Crypto Bill After Republican Standoff

Ava Grace 2025 Jul 17, 01:20

US Bankers Defend Federal Reserve Independence Amid Political Pressure

Noah Lee 2025 Jul 17, 01:20

US Economy in Uncertainty: Tariffs and Labor Shortages Worry Businesses

Info

Spread

0.05

Spread (%)

0.7194 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar buka

Kamis

13:31 - 19:59

Senin

13:31-19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Jumat

13:31-19:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

1114353664

Saham yang Beredar

161970000

Tanggal Penghasilan (Berikutnya)

2019-05-10

Hasil Div

2019-05-10

Tanggal Non-Dividen

Proyeksi tingkat dividen tahunan

0

Proyeksi hasil dividen tahunan

0

EPS

2.75

Pelajari lebih lanjut tentang instrumen ini

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

latest_education_articles

Tampilkan lebih banyak
Trustpilot